Navigation Links
Targanta to Present at Lazard Capital Markets Fourth Annual Healthcare Conference
Date:11/20/2007

Presentation to be Webcast at 2:00 pm ET on November 27, 2007

CAMBRIDGE, Mass., Nov. 20 /PRNewswire-FirstCall/ -- Targanta Therapeutics Corporation (Nasdaq: TARG) today announced its participation in the Lazard Capital Markets Fourth Annual Healthcare Conference, taking place November 27 and 28, 2007 at the New York Palace Hotel in New York City. Mark Leuchtenberger, President and Chief Executive Officer of Targanta, will be presenting at 2:00 pm ET on Tuesday, November 27, 2007.

The audio portion of the presentation will be webcast live and the replay available for 30 days via http://www.wsw.com/webcast/lz4/targ/, or through the Investor Relations section of Targanta's website at http://www.targanta.com/investors.

About Targanta Therapeutics

Targanta Therapeutics Corporation is a biopharmaceutical company focused on developing and commercializing innovative antibiotics to treat serious infections in the hospital and other institutional settings. The Company's pipeline includes oritavancin, a semi-synthetic lipoglycopeptide antibiotic, for which Targanta intends to seek U.S. regulatory approval in early 2008, as well as a number of antibacterial agents in pre-clinical development. The company has operations in Cambridge, MA, Indianapolis, IN, Montreal, Quebec, Canada and Toronto, Ontario, Canada. To find out more about Targanta (Nasdaq:

SOURCE Targanta Therapeutics Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Targanta Therapeutics to Have Significant Presence at 47th Annual ICAAC Meeting
2. Targanta Therapeutics Announces Pricing of its Initial Public Offering
3. Targanta to Present at 9th Annual Mass Opportunities Investment Conference
4. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
5. Avicena Group to Present at Noble Financial Conference
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
8. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
9. CEL-SCI to Present at the Noble Financial Conference
10. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
11. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... CANTON, Mass. and NEW ORLEANS ... commercial leader in the field of regenerative medicine, presented ... expert economists from Analysis Group (a leading health economics ... that diabetic foot ulcers (DFU) and venous leg ulcers ... The results of this research, which reveal annual ...
(Date:5/22/2013)... 2013 Mold remediation could take a toll ... is a way to cut down the process' expense. And ... post the details of a method how to kill ... could be prevented, My Cleaning Products said. But in case ... a mold remediation must then be promptly implemented as it ...
(Date:5/22/2013)... May 22, 2013 A recent study from ... on athletes to find that those who took probiotics were ... results from the study showed that in extreme heat conditions, ... for their adult acne treatment explains what this ... it may help their skin condition. , While researchers ...
(Date:5/21/2013)... , May 21, 2013  On May 9, ... ), the global business advisory firm dedicated to ... (the "Company"), announced that it has combined the ... formerly included within the Corporate Finance/Restructuring segment with ... to form a single integrated practice whose financial ...
Breaking Biology Technology:Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 2Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 3Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 4How to Kill Mold While Saving Thousands of Dollars on Mold Remediation Projects Explained by My Cleaning Products 2Adult Acne Treatment, Probiotic Action Shares Insight on New Findings Between Probiotics and Heat Tolerance, and What It Means for Acne Sufferers 2FTI Consulting Releases Realigned Segment Information Reflecting Newly Combined Health Solutions Practice 2
... /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq:,ONTY) (TSX: ONY) (the "Company") ... per basic and diluted share for the quarter ended ... basic and diluted share for the,comparable period in 2007. ... was $2.0 million in the first quarter of 2008, ...
... PITTSBURGH, May 7 Mylan Inc. (NYSE: MYL ... approval,from the U.S. Food and Drug Administration (FDA) for ... 0.25 mg,(base), 0.5 mg (base), 1 mg (base), 2 ... mg (base)., Ropinirole Hydrochloride Tablets are the generic ...
... $17 ... Million, TUCSON, Ariz., ... it has signed a letter of intent in,which Microbix Biosystems will acquire ... is an FDA-approved,thrombolytic, or clot-dissolving agent, indicated for the treatment of,acute massive ...
Cached Biology Technology:Oncothyreon Reports First Quarter 2008 Financial Results 2Oncothyreon Reports First Quarter 2008 Financial Results 3Oncothyreon Reports First Quarter 2008 Financial Results 4Oncothyreon Reports First Quarter 2008 Financial Results 5ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase 2ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase 3ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase 4
(Date:5/21/2013)... for a long time that some creatures evolve more ... for plants. But it may be that height plays ... and the U. S. National Evolutionary Synthesis Center. ... in the journal Nature Communications , Lanfear and ... Drawing from a database of global patterns in plant ...
(Date:5/21/2013)... in the body, stem cells in the blood ... into mature immune cells that can fight off ... these cell populations, potentially leading to the development ... a team of researchers led by biologists at ... that, in mouse models, the molecule microRNA-146a (miR-146a) ...
(Date:5/21/2013)... ANN ARBORThe new University of Michigan Water Center ... to support Great Lakes restoration and protection efforts. ... will support diverse projects, including efforts to track ... effectiveness of techniques to control non-native weedy plant ... and monitor fish responses to restoration activities. , ...
Breaking Biology News(10 mins):Small but speedy: Short plants live in the evolutionary fast lane 2Keeping stem cells strong 2U-M Water Center awards $570K in Great Lakes restoration grants 2U-M Water Center awards $570K in Great Lakes restoration grants 3U-M Water Center awards $570K in Great Lakes restoration grants 4
... January 18, 2011 Using chemical compounds found in a ... ultraviolet light, a Scripps Research Institute team has created a ... biomedical potential. Already, one of the compounds has shown great ... With the report of their work scheduled to ...
... Soy protein,s ability to lower total and ... been extensively studied, but the mechanism whereby soy ... published in the Journal of Clinical Lipidology ... total cholesterol and non-HDL (non-high-density lipoprotein) cholesterol significantly ...
... EAST LANSING, Mich. The downsides of China,s explosive ... now are joined by an upside: Better environmental citizens. ... and leadership when considering environmental behavior in China,s cities. ... Environmental Conservation , scientists at the Center for ...
Cached Biology News:Scripps Research team creates new synthetic compound with HIV-fighting promise 2Scripps Research team creates new synthetic compound with HIV-fighting promise 3New study shows soy protein lowers non-HDL cholesterol significantly more than milk protein 2Big city life may make residents lean toward green, study says 2
Cytofix/Cytoperm Kit 250 Tests...
Cytofix/Cytoperm Plus Kit with GolgiPlug 250 Tests...
Complete PCR kit. Includes: MasterAmp™ Taq DNA Polymerase, 10X PCR Buffer, MasterAmp™ 10X PCR Enhancer, dNTP Mix, 2.5 mM each, 25 mM MgCl2, Enzyme Dilution Buffer, Control Template and Prim...
Mouse monoclonal to OCIL ( Abpromise for all tested applications)....
Biology Products: